Clinical trials recruiting in North Sydney, Australia
8
Recruiting trials
14
Conditions
Phase breakdown
Phase 2 1Phase 3 5Not applicable 2
Conditions recruiting in North Sydney, Australia
Recruiting trials in North Sydney, Australia
- A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)
- A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
- DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
- Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy
- Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
Common questions
How many clinical trials are recruiting in North Sydney, Australia?
8 recruiting trials have at least one study site in North Sydney, Australia.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.